tiprankstipranks
Takeda: Japanese MHLW approves LIVTENCITY
PremiumThe FlyTakeda: Japanese MHLW approves LIVTENCITY
24d ago
Takeda receives approval from European Commission for FRUZAQLA
PremiumThe Fly
Takeda receives approval from European Commission for FRUZAQLA
27d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
27d ago
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
PremiumThe FlyOppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
30d ago
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
PremiumThe Fly
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
30d ago
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
30d ago
Healwell AI, Takeda partner to support rare disease RWE analysis
PremiumThe FlyHealwell AI, Takeda partner to support rare disease RWE analysis
1M ago
Takeda presents results from Phase 2b trial of TAK-861 in NT1
PremiumThe Fly
Takeda presents results from Phase 2b trial of TAK-861 in NT1
1M ago
Takeda, Pfizer announce four-year results from Phase 3 HD21 trial
PremiumThe Fly
Takeda, Pfizer announce four-year results from Phase 3 HD21 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100